Supriya Lifescience gets CEP for Diphenhydramine Hydrochloride

29 Sep 2022 Evaluate

Supriya Lifescience has received Certification of Suitability (CEP) from European Directorate for the Quality of Medicines and HealthCare (EDQM). CEP is for Diphenhydramine Hydrochloride, API in AntiHistamine therapy. This will be an added advantage for Supriya Lifescience in the European market. Global demand for Diphenhydramine Hydrochloride is 1850 tons, of which major demand is in the regulated markets.

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.

Supriya Lifescience Share Price

738.75 -16.90 (-2.24%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×